How has Ireland’s pharma sector developed?
Nine of the ten largest pharmaceutical companies in the world are present in Ireland. The sector has matured rapidly and is a significant contributor to Ireland’s economic success. Chanelle Pharma is unique as it remains an Irish owned company, and is heavily committed to R&D and exporting to over 96 countries.
How innovative is Irish pharma?
Chanelle Pharma received a lot of support in its early years from Enterprise Ireland, and we continue to receive support particularly for our R&D investments. Developing new products has been key to our success and we have launched nearly 75 products in human and veterinary forms through innovative generic combinations. We are targeting liquid and spot on products, and have a strong pipeline of products to cater for the US market.
What are Chanelle Pharma’s US plans?
Chanelle Pharma is currently undertaking an ambitious 86 million euro investment program to support its U.S. expansion. We believe our product range, dedicated manufacturing facility and ability to produce competitively priced generic liquid pharmaceuticals will be attractive to US manufacturers and distributers. We work closely with our customers to produce a product that is affordable, accessible and effective. Our core values of integrity, respect, collaboration, excellence and leadership, enable us to bring safe and effective medicines to the world.